These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23625867)

  • 1. Immediate effects of individualized heparin and protamine management on hemostatic activation and platelet function in adult patients undergoing cardiac surgery with tranexamic acid antifibrinolytic therapy.
    Hofmann B; Bushnaq H; Kraus FB; Raspé C; Simm A; Silber RE; Ludwig-Kraus B
    Perfusion; 2013 Sep; 28(5):412-8. PubMed ID: 23625867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine?
    Gertler R; Wiesner G; Tassani-Prell P; Braun SL; Martin K
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):981-6. PubMed ID: 21315618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating protamine-heparin-antibodies lead to higher protamine demand in patients undergoing cardiac surgery.
    Grieshaber P; Bakchoul T; Wilhelm J; Wagner A; Wollbrück M; Böning A; Sachs U
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):967-73.e1. PubMed ID: 26298870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass.
    Shigeta O; Kojima H; Hiramatsu Y; Jikuya T; Terada Y; Atsumi N; Sakakibara Y; Nagasawa T; Mitsui T
    J Thorac Cardiovasc Surg; 1999 Aug; 118(2):354-60. PubMed ID: 10425010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of heparin resistance with Antithrombin III in cardiac surgery.
    Kanbak M
    Can J Anaesth; 1999 Jun; 46(6):581-5. PubMed ID: 10391608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass.
    Gruenwald CE; Manlhiot C; Chan AK; Crawford-Lean L; Foreman C; Holtby HM; Van Arsdell GS; Richards R; Moriarty H; McCrindle BW
    J Am Coll Cardiol; 2010 Nov; 56(22):1794-802. PubMed ID: 21087706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
    Levin AI; Heine AM; Coetzee JF; Coetzee A
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery.
    Pleym H; Stenseth R; Wahba A; Bjella L; Karevold A; Dale O
    Anesth Analg; 2003 Apr; 96(4):923-928. PubMed ID: 12651635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic acid decreases the magnitude of platelet dysfunction in aspirin-free patients undergoing cardiac surgery with cardiopulmonary bypass: a pilot study.
    Van Aelbrouck C; Jorquera-Vasquez S; Beukinga I; Pradier O; Ickx B; Barvais L; Van Obbergh L; Faraoni D
    Blood Coagul Fibrinolysis; 2016 Dec; 27(8):855-861. PubMed ID: 27388281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
    Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated protamine dose assay in heparin reversal management after cardiopulmonary by pass.
    Guarracino F; De Cosmo D; Penzo D; Tedesco M; Bossi A; Zussa C; Polesel E; De Stefani R
    Minerva Anestesiol; 2001 Apr; 67(4):165-9. PubMed ID: 11376504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation.
    Koster A; Fischer T; Gruendel M; Mappes A; Kuebler WM; Bauer M; Kuppe H
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):171-5. PubMed ID: 12698397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial.
    Arsenault KA; Paikin JS; Hirsh J; Dale B; Whitlock RP; Teoh K; Young E; Ginsberg JS; Weitz JI; Eikelboom JW
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):944-950.e3. PubMed ID: 22743176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.